{
    "title": "107_hr698",
    "content": "The Act is titled the \"Prescription Reimportation, Improvement, Correction, and Enhancement Act.\" It includes amendments to the program for importation of certain prescription drugs by pharmacists and wholesalers. Section 804 of the Federal Food, Drug, and Cosmetic Act is amended to require testing of covered products by importers or manufacturers, with necessary authentication information provided. Section 804 of the Federal Food, Drug, and Cosmetic Act is amended to require testing of covered products by importers or manufacturers, with necessary authentication information provided. Importers can use approved labeling for imported products, and the Secretary has discretion to waive or modify testing requirements under certain conditions. The amendment to Section 804 of the Federal Food, Drug, and Cosmetic Act prohibits manufacturers from entering agreements preventing the sale of imported products and prohibits discrimination against US pharmacists, wholesalers, or consumers. The Comptroller General of the United States will conduct a study on permitted imports. The Comptroller General will conduct a study on permitted imports, evaluating importers' compliance with regulations and consulting with relevant agencies. A report must be submitted within 5 years of final regulations being issued. The Comptroller General will prepare a report for Congress on a study regarding discrimination in access to covered products by pharmacists, wholesalers, or consumers. Subsection (k)(2) is amended to include provisions on discrimination. The amendment includes provisions for funding necessary for carrying out the section in fiscal year 2002 and subsequent years."
}